Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 10 of 57328 results
Sort by: relevance publication year
Showing results for ISSN matching 0923-7534

387P A comprehensive analysis of the oral health status, tobacco use, and cancer prevalence among the tribal communities in India

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: D.L. Francis | S. Sampoornam Pape | S.S. Chopra

https://doi.org/10.1016/j.annonc.2023.10.722 Actions

29P HUWE1 inhibition has tumor suppressive effect in triple-negative breast cancer cell lines by modulating glycolytic and immune modulatory markers

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: S. Kahol | S. Mathur

https://doi.org/10.1016/j.annonc.2023.10.789 Actions

209MO A phase II study of tislelizumab(T) as neoadjuvant treatment for cisplatin-ineligible high risk upper tract urothelial carcinoma (UTUC)

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: J. Huang | X. Cai | W. Kong | J. Zhang | Y. Chen | H. Chen | W. Xue

https://doi.org/10.1016/j.annonc.2023.10.345 Actions

572P Multivariable five-year survival prediction model for prognosing patients with EGFR-mutated NSCLC treated with EGFR-TKIs

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: Q-A. Wang | C.T. Yang | C-H.S. Kuo | P-C. Hsu | J.W-C. Chang | C-E. Wu

https://doi.org/10.1016/j.annonc.2023.10.650 Actions

348P In-depth molecular analysis in the diagnosis of lymphomas with lymphoplasmacytic differentiation may provide a more precise diagnosis and rational treatment allocation

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: E. Willenbacher | W. Willenbacher | A. Brunner

https://doi.org/10.1016/j.annonc.2023.10.730 Actions

169P Conversion response and prognostic factors in HCC patients with macrovascular invasion treated with atezolizumab plus bevacizumab

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: K. Wang | H. Sun | X. Bai | Z-Y. Huang | T. Song | M. Chen | M. Kuang | B. Xiang | Y. Zeng | L-X. Liu | D. Li | Y. Chen | J. Cai | B. Xing | T. Peng | X. Zhang | X. Zhu | J. Zhou | J. Fan | F. Shen

https://doi.org/10.1016/j.annonc.2023.10.304 Actions

243P Targeting autophagy in tumor-associated macrophages effects the phenotype and tumor progression in urothelial carcinoma of bladder

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: A. Singh

https://doi.org/10.1016/j.annonc.2023.10.379 Actions

240P Efficacy and safety of first-line combination therapy with ipilimumab + nivolumab for metastatic renal cell carcinoma in a single institution in Japan

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: M. Nagata | S. Horie | N. Nagaya

https://doi.org/10.1016/j.annonc.2023.10.376 Actions

74MO Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2-expressing solid tumors: Primary analysis from the DESTINY-PanTumor02 (DP-02) study

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: D-Y. Oh | F. Meric-Bernstam | V. Makker | A. Oaknin | S. Banerjee | A. Gonzalez Martin | K.H. Jung | I. Lugowska | L.M. Manso | A. Manzano | B. Melichar | S. Siena | D. Stroyakovskiy | A. Fielding | Y. Ma | S.D. Puvvada | J-Y. Lee

https://doi.org/10.1016/j.annonc.2023.10.209 Actions

560P Triple-targeted therapy of dabrafenib, trametinib and osimertinib for the treatment of acquired BRAF V600E mutation after progression on EGFR-TKIs in advanced EGFR-mutant NSCLC

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: C. Weng | K. Tang | S. Jin | C. Zhou | Y. Yao | J-W. Su | H. Chen | K. Liu | Y. Li | J. Yang

https://doi.org/10.1016/j.annonc.2023.10.638 Actions

190P Perioperative camrelizumab combined with chemotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: A single-arm, single-center, phase II clinical trial

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: J. He | Y. Yang | S. Zhou | B. Zhang | Z. Han | T. Wu | Q. Qiao | H. Yang | X. He | N. Wang

https://doi.org/10.1016/j.annonc.2023.10.769 Actions

597TiP A phase I/II study to evaluate the safety and anti-tumor activity of JIN-A02 in patients with EGFR TKI-refractory, EGFR-mutant advanced NSCLC

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: S.M. Lim | B.C. Cho | J-Y. Han | S-W. Kim | K.H. Lee | M. Nagasaka | T.R. Baisamut | A. Jo | E. Seah | C. Kim | S-H.I. Ou

https://doi.org/10.1016/j.annonc.2023.10.675 Actions

382P Oral health disparities in privileged and underprivileged tribes of south India: A study of the prevalence of precancerous oral lesions

JOURNAL ARTICLE published November 2023 in Annals of Oncology

Authors: S.A. Palliyal

https://doi.org/10.1016/j.annonc.2023.10.717 Actions

1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression

JOURNAL ARTICLE published September 2021 in Annals of Oncology

Authors: Z. Andric | T. Ceric | M. Rancic | M. Jakopovic | S. Ponce Aix | R. Ramlau | M. Ulanska | C. Caldwell | D. Ferrari | A. Annis | V. Vukovic | B. Zaric

https://doi.org/10.1016/j.annonc.2021.08.238 Actions

Pembrolizumab with or without chemotherapy vs chemotherapy in patients with advanced G/GEJ cancer (GC) including outcomes according to Microsatellite Instability-High (MSI-H) status in KEYNOTE-062

JOURNAL ARTICLE published October 2019 in Annals of Oncology

Authors: K. Shitara | E. Van Cutsem | Y.-J. Bang | C.S. Fuchs | L. Wyrwicz | K.W. Lee | I. Kudaba | M. Garrido | H. Cheol Chung | H.R. Castro | W. Mansoor | M I F M Braghiroli | E. Goekkurt | J. Chao | Z.A. Wainberg | U. Kher | S. Shah | S.P. Kang | J. Tabernero

https://doi.org/10.1093/annonc/mdz394.035 Actions

O-9 Discordant prognostic significance of negative lymph node size in patients with oesophageal cancer treated with either surgery or neoadjuvant chemotherapy and surgery: Results from the MRC OE02 trial

JOURNAL ARTICLE published July 2020 in Annals of Oncology

Authors: M. Kloft | J. Ruisch | M. Nankivell | W. Allum | D. Cunningham | R. Langley | H. Grabsch

https://doi.org/10.1016/j.annonc.2020.04.062 Actions

SO-20 Prospective validation of Ang-2 and Tie-2 plasma levels as predictors of benefit from regorafenib in metastatic colorectal cancer patients: REGOLAND study

JOURNAL ARTICLE published July 2021 in Annals of Oncology

Authors: C. Antoniotti | F. Marmorino | A. Boccaccino | M. Antista | N. Zaffaroni | G. Zucchelli | A. Martinetti | E. Campi | D. Rossini | E. Sottotetti | B. Borelli | F. Corti | V. Conca | R. Moretto | M. Germani | A. Falcone | M. Giordano | G. Masi | F. Pietrantonio | C. Cremolini

https://doi.org/10.1016/j.annonc.2021.05.044 Actions

Targeting Cancer Aneuploidy: Light at the End of the Tunnel?

JOURNAL ARTICLE published September 2014 in Annals of Oncology

Authors: T.W. Mak

https://doi.org/10.1093/annonc/mdu290.4 Actions

Table of Contents

JOURNAL ARTICLE published December 2019 in Annals of Oncology

https://doi.org/10.1016/s0923-7534(20)32571-0 Actions

Aspirin to prevent gastrointestinal cancer – but recent trial data do not fit

JOURNAL ARTICLE published September 2020 in Annals of Oncology

Authors: A.P. Jacobsen | Y.C. Khiew | R.S. Blumenthal | S.S. Martin

https://doi.org/10.1016/j.annonc.2020.05.002 Actions
Feedback: support@crossref.org